Spectranetics' (SPNC) AngioSculptX Receives CE Mark

August 10, 2016 9:01 AM EDT Send to a Friend
The Spectranetics Corporation (Nasdaq: SPNC) announced receipt of CE marking for the AngioSculptX Drug-coated PTCA Scoring Balloon Catheter. AngioSculptX is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login